The inhibition of TXNIP expression, inflammation, and ER stress through the activation of the adenosine monophosphate‐activated protein kinase (AMPK) pathway establishes a protective effect against retinal neurodegeneration in diabetes. This evidence concerns the gene TXNIP and diabetes mellitus.